| 
                        1.
                     | 
                        Sandostatin
                     | 
                        Inj Lös 0.05 mg/ml 
                     | 
                        5 Amp 1 ml
                     | 
                        22.19
                     | 
                        40.40
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        49137028
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        15538
                     | 
                        15.03.1989
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     | 
					
						| 
                        2.
                     | 
                        Sandostatin
                     | 
                        Inj Lös 0.1 mg/ml 
                     | 
                        5 Amp 1 ml
                     | 
                        41.38
                     | 
                        61.15
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        49137044
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        15538
                     | 
                        15.03.1989
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     | 
					
						| 
                        3.
                     | 
                        Sandostatin
                     | 
                        Inj Lös 0.5 mg/ml 
                     | 
                        5 Amp 1 ml
                     | 
                        227.65
                     | 
                        262.60
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        49137079
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        15538
                     | 
                        15.03.1997
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     | 
					
						| 
                        4.
                     | 
                        Sandostatin LAR
                     | 
                        Trockensub 10 mg c Sol
                     | 
                        1 Stk
                     | 
                        505.79
                     | 
                        560.55
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        53161004
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        16484
                     | 
                        15.03.1997
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     | 
					
						| 
                        5.
                     | 
                        Sandostatin LAR
                     | 
                        Trockensub 20 mg c Sol
                     | 
                        1 Stk
                     | 
                        897.90
                     | 
                        982.40
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        53161005
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        16484
                     | 
                        15.03.1997
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     | 
					
						| 
                        6.
                     | 
                        Sandostatin LAR
                     | 
                        Trockensub 30 mg c Sol
                     | 
                        1 Stk
                     | 
                        1265.46
                     | 
                        1377.85
                     | 
                        01.12.2023
                     | 
                                                
                     | 
                        
                     | 
                      L
                     | 
                        Nein                        
                     | 
                        53161006
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Octreotidum
                     | 
                        16484
                     | 
                        15.03.1997
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                        O 
                     | 
                        07.16.20.
                     | 
                        H01CB02
                     |